We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$392M
AUM Growth
+$17.6M
Cap. Flow
+$3.68M
Cap. Flow %
0.94%
Top 10 Hldgs %
60.17%
Holding
139
New
22
Increased
37
Reduced
35
Closed
10

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$7.69M
2
ALXO icon
ALX Oncology
ALXO
+$4.88M
3
AMD icon
Advanced Micro Devices
AMD
+$4.75M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$1.56M
5
ASTSW
AST SpaceMobile, Inc. Warrant
ASTSW
+$1.51M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$6.02M
2
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$5.35M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.37M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$3.3M
5
MRNA icon
Moderna
MRNA
+$2.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.59%
2 Healthcare 24.36%
3 Technology 24.32%
4 Communication Services 14.32%
5 Miscellaneous 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DFNSW
126
T3 Defense Inc Warrants
DFNSW
$531K
$2.25K ﹤0.01%
74,933
– –
SHPWW
127
DELISTED
Shapeways Holdings, Inc. Warrants
SHPWW
$1.79K ﹤0.01%
313,646
– –
REVBW icon
128
Revelation Biosciences Warrant
REVBW
$752 ﹤0.01%
44,000
– –
EVLVW
129
DELISTED
Evolv Technologies Warrant
EVLVW
– –
-131,963
Closed -$80.5K
GPK icon
130
Graphic Packaging
GPK
$3.42B
– –
-19,411
Closed -$566K
LBTYA icon
131
Liberty Global Class A
LBTYA
$3.64B
– –
-87,400
Closed -$1.48M
NTLA icon
132
Intellia Therapeutics
NTLA
$1.8B
– –
-8,905
Closed -$245K
NVS icon
133
Novartis
NVS
$292B
– –
-6,000
Closed -$580K
PTGX icon
134
Protagonist Therapeutics
PTGX
$9.34B
– –
-114,024
Closed -$3.3M
HGASW
135
DELISTED
Global Gas Corporation Warrant
HGASW
– –
-40,637
Closed -$1.63K
FUSN
136
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-251,158
Closed -$5.35M
PUCKW
137
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
– –
-73,577
Closed -$464
MIR.WS
138
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
– –
-532,730
Closed -$1.19M
2 3 4 5
6

Similar funds

RWMH
Riverpoint Wealth Management Holdings Chicago, Illinois $544M AUM 20.39% 1-Year Est. Return
BPIA
Broad Peak Investment Advisers Singapore $544M AUM 132.56% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $544M AUM 70.51% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
FIM
FWL Investment Management Dallas, Texas $545M AUM 64.06% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
CCM
Coerente Capital Management Toronto, Ontario, Canada $543M AUM 7.53% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Privium Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, Privium Fund Management held 139 positions worth $392M, up 4.7% from $374M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Privium Fund Management's Q2 2024 filing shows 22 new, 37 increased, 35 reduced and 10 closed positions. Its largest new stake was ALX Oncology: 396,966 shares worth $2.27M. The largest sale was Spotify, an estimated $6.02M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

  • Privium Fund Management's largest Q2 2024 buy was ALX Oncology: 396,966 shares worth $2.27M.
  • Privium Fund Management added most to Tesla in Q2 2024, an estimated $7.69M increase.
  • Privium Fund Management's biggest Q2 2024 reduction was Spotify, cutting an estimated $6.02M.
  • Privium Fund Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $5.35M.
  • Privium Fund Management's ten largest holdings make up 60% of its $392M portfolio in Q2 2024.
  • Privium Fund Management opened 22 new positions and closed 10 in Q2 2024.
  • Privium Fund Management's portfolio value rose 4.7% quarter-over-quarter to $392M.

Based on Privium Fund Management's 13F filing for Q2 2024, filed 1 Aug 2024.